女性痤疮的激素治疗
Hormonal treatment of acne in women.
作者信息
Ebede Tobechi L, Arch Emily L, Berson Diane
出版信息
J Clin Aesthet Dermatol. 2009 Dec;2(12):16-22.
Abstract
Acne vulgaris is a common and chronic disorder of the pilosebaceous unit. Standard treatment protocols include topical retinoids, topical and oral antimicrobials, and isotretinoin. Hormonal therapies can be added to the regimen in some patients. This article will review the hormonal pathogenesis of acne, discuss the basics of an endocrine evaluation, and provide an overview of the current hormonal treatment options in women.
摘要
寻常痤疮是一种常见的毛囊皮脂腺慢性疾病。标准治疗方案包括外用维甲酸、外用和口服抗菌药物以及异维甲酸。在某些患者中，可在治疗方案中添加激素疗法。本文将综述痤疮的激素发病机制，讨论内分泌评估的基础知识，并概述目前女性的激素治疗选择。
相似文献
1
Hormonal treatment of acne in women.
J Clin Aesthet Dermatol. 2009 Dec;2(12):16-22.
2
Treatment of acne vulgaris.
JAMA. 2004 Aug 11;292(6):726-35. doi: 10.1001/jama.292.6.726.
3
Hormonal treatment of acne vulgaris: an update.
Clin Cosmet Investig Dermatol. 2016 Sep 2;9:241-8. doi: 10.2147/CCID.S114830. eCollection 2016.
4
Acne. A review of optimum treatment.
Drugs. 1994 Jul;48(1):59-70. doi: 10.2165/00003495-199448010-00006.
5
Acne in the first three decades of life: An update of a disorder with profound implications for all decades of life.
Dis Mon. 2021 Apr;67(4):101103. doi: 10.1016/j.disamonth.2020.101103. Epub 2020 Oct 9.
6
Contraceptive use in acne.
Clin Dermatol. 2014 Jul-Aug;32(4):502-15. doi: 10.1016/j.clindermatol.2014.05.002.
7
Acne: effect of hormones on pathogenesis and management.
Am J Clin Dermatol. 2002;3(8):571-8. doi: 10.2165/00128071-200203080-00007.
8
Pharmacologic modulation of sebaceous gland activity: mechanisms and clinical applications.
Dermatol Clin. 2007 Apr;25(2):137-46, v. doi: 10.1016/j.det.2007.01.004.
9
Endocrinological evaluation and hormonal therapy for women with difficult acne.
J Eur Acad Dermatol Venereol. 2001;15 Suppl 3:57-61. doi: 10.1046/j.0926-9959.2001.00014.x.
10
The treatment of acne with topical retinoids: one man's opinions.
J Am Acad Dermatol. 1997 Jun;36(6 Pt 2):S92-5. doi: 10.1016/s0190-9622(97)70049-5.
引用本文的文献
1
Multifactorial Refractory Acne in Women: Insights from a Case Series Involving Hormonal-, Metabolic-, and Corticosteroid-Related Triggers.
Life (Basel). 2025 Jul 28;15(8):1196. doi: 10.3390/life15081196.
2
Decoding Acne Vulgaris: Insights into Pathogenesis, Treatment Modalities, Diagnosis and Recent Advancements.
Recent Adv Inflamm Allergy Drug Discov. 2025;19(1):18-30. doi: 10.2174/0127722708312980240718093537.
3
Efficacy and safety of Spironolactone in treating patients with acne vulgaris: a systematic review and meta-analysis of 1,086 patients.
Arch Dermatol Res. 2025 Feb 1;317(1):328. doi: 10.1007/s00403-025-03815-w.
4
The role of current synthetic and possible plant and marine phytochemical compounds in the treatment of acne.
RSC Adv. 2024 Aug 5;14(33):24287-24321. doi: 10.1039/d4ra03865g. eCollection 2024 Jul 26.
5
Exploring Acne Treatments: From Pathophysiological Mechanisms to Emerging Therapies.
Int J Mol Sci. 2024 May 13;25(10):5302. doi: 10.3390/ijms25105302.
6
Melatonin Related Acneiform Lesions: A Case Report and Potential Mechanism.
Psychiatry Clin Psychopharmacol. 2021 Jun 1;31(2):241-244. doi: 10.5152/pcp.2021.21234. eCollection 2021 Jun.
7
Acne vulgaris: A review of the pathophysiology, treatment, and recent nanotechnology based advances.
Biochem Biophys Rep. 2023 Nov 23;36:101578. doi: 10.1016/j.bbrep.2023.101578. eCollection 2023 Dec.
8
Acne accounts for an almost 2.5-fold higher proportion of dermatology visits among adult females compared to adult males in the United States: A study of the national ambulatory medical care survey from 2002-2016.
PLoS One. 2023 Sep 21;18(9):e0290763. doi: 10.1371/journal.pone.0290763. eCollection 2023.
9
A Pilot Study of Clindamycin Phosphate 1.2% and Benzoyl Peroxide 3.75% Combination Gel in the Treatment of Perimenstrual Acne.
J Clin Aesthet Dermatol. 2022 Nov;15(11):18-21.
10
Association between exposure to ambient air pollution and occurrence of inflammatory acne in the adult population.
BMC Public Health. 2021 Sep 14;21(1):1664. doi: 10.1186/s12889-021-11738-0.
本文引用的文献
1
Pathogenesis of acne vulgaris: recent advances.
J Drugs Dermatol. 2009 Jul;8(7):615-8.
2
New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group.
J Am Acad Dermatol. 2009 May;60(5 Suppl):S1-50. doi: 10.1016/j.jaad.2009.01.019.
3
Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
Cochrane Database Syst Rev. 2009 Apr 15(2):CD000194. doi: 10.1002/14651858.CD000194.pub2.
4
Treatment of acne using a 3-milligram drospirenone/20-microgram ethinyl estradiol oral contraceptive administered in a 24/4 regimen: a randomized controlled trial.
Obstet Gynecol. 2008 Oct;112(4):773-81. doi: 10.1097/AOG.0b013e318187e1c5.
5
6
Hormonal therapy for acne.
Semin Cutan Med Surg. 2008 Sep;27(3):188-96. doi: 10.1016/j.sder.2008.06.002.
7
Oral contraceptives, hormone therapy and cardiovascular risk.
Climacteric. 2008 Oct;11(5):355-63. doi: 10.1080/13697130802322848.
8
Frontiers in sebaceous gland biology and pathology.
Exp Dermatol. 2008 Jun;17(6):542-51. doi: 10.1111/j.1600-0625.2008.00725.x.
9
Acne and oral contraceptives: update on women's health screening guidelines.
J Am Acad Dermatol. 2008 May;58(5):781-6. doi: 10.1016/j.jaad.2007.12.040. Epub 2008 Mar 24.
10
Hormonal contraceptives for acne management.
Cutis. 2008 Jan;81(1 Suppl):13-8.
Zotero 插件